tirzepatide legal battle Novo sues Lilly, claiming misleading ads in weight-loss drug The legal battle continues –

This article covers clinical evidence, biomarker context, and how genetic predispositions in peptide pat

Scientists analyzed electronic medical records for more than 73,000 people and found that after 5 years, GLP-1 use was linked to a significantly higher risk of developing osteoporosis, compared to those not taking the medication

What is FuturHealth

If side effects occur, your care team may adjust dosage, timing, or treatment strategy based on clinical judgment and your feedback

The DIAMOND study compared the effectiveness of rtCGM with glucose self-monitoring in adults with T1DM and T2DM aged 60 years and older on MDIs

If you are wondering whether a personalized treatment plan is right for you, you can take the free assessment quiz to see what options may fit your goals